MetaCap

Atea Pharmaceuticals Insider Trades

NASDAQ: AVIRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.96+0.03 (+0.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $25.45K
Sales
6 · $319.80K
Shares bought / sold
6.10K / 79.34K
Net activity
Net selling $294,358

Atea Pharmaceuticals insider activity

Over the last 12 months, Atea Pharmaceuticals insiders reported 32 transactions on SEC Form 4: 1 open-market purchase and 6 sales. Insiders bought $25,446 and sold $319,804 worth of stock, for net insider selling of $294,358. The largest seller was Polsky Bruce, with $203,393 in reported sales.

The most recent filing shows Polsky Bruce (Director) selling 8,750 shares at $4.03 on Nov 19, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AVIR's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AVIR insider transactions

Atea Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Nov 19, 2026Lucidi BrunoDirectorSale22,619$89.22KForm 4
Nov 19, 2026Lucidi BrunoDirectorOption exercise53,372$66.18KForm 4
Nov 19, 2026Polsky BruceDirectorSale8,750$35.30KForm 4
Nov 18, 2026Polsky BruceDirectorSale18,252$72.10KForm 4
Nov 18, 2026Polsky BruceDirectorOption exercise18,252$22.63KForm 4
Nov 17, 2026Polsky BruceDirectorSale8,720$35.16KForm 4
Nov 17, 2026Polsky BruceDirectorOption exercise8,720$10.81KForm 4
Nov 17, 2026Lucidi BrunoDirectorSale6,741$27.19KForm 4
Nov 17, 2026Lucidi BrunoDirectorOption exercise21,628$26.82KForm 4
Nov 16, 2026Polsky BruceDirectorSale14,254$60.84KForm 4
Nov 16, 2026Polsky BruceDirectorOption exercise48,028$59.55KForm 4
Jun 18, 2026Adams Jerome M.DirectorOption exercise29,600—Form 4
Jun 18, 2026Polsky BruceDirectorOption exercise29,600—Form 4
Jun 18, 2026BERGER FRANKLIN MDirectorOption exercise29,600—Form 4
Jun 18, 2026Lucidi BrunoDirectorOption exercise29,600—Form 4
Jun 18, 2026Murphy Polly A.DirectorOption exercise29,600—Form 4
Jun 18, 2026DUNCAN BARBARA GAYLEDirectorOption exercise29,600—Form 4
May 18, 2026Murphy Polly A.DirectorBuy6,100$25.45KForm 4
Mar 11, 2026Corcoran AndreaSee RemarksOption exercise60,000$74.40KForm 4
Feb 3, 2026Sommadossi Jean-PierrePresident, CEO, and ChairmanOption exercise300,000$372.00KForm 4
Jan 31, 2026Foster WayneEVP, Chief Accounting OfficerTax withholding12,132$51.44KForm 4
Jan 31, 2026Foster WayneEVP, Chief Accounting OfficerOption exercise41,333—Form 4
Jan 31, 2026Sommadossi Jean-PierrePresident, CEO, and ChairmanTax withholding106,093$449.83KForm 4
Jan 31, 2026Sommadossi Jean-PierrePresident, CEO, and ChairmanOption exercise272,983—Form 4
Jan 31, 2026Corcoran AndreaSee RemarksTax withholding16,104$68.28KForm 4
Jan 31, 2026Corcoran AndreaSee RemarksOption exercise54,866—Form 4
Jan 31, 2026Hammond Janet MJChief Development OfficerTax withholding14,136$59.94KForm 4
Jan 31, 2026Hammond Janet MJChief Development OfficerOption exercise58,050—Form 4
Jan 31, 2026Vavricka JohnChief Commercial OfficerTax withholding11,570$49.06KForm 4
Jan 31, 2026Vavricka JohnChief Commercial OfficerOption exercise42,083—Form 4
Jan 31, 2026Horga Maria ArantxaChief Medical OfficerTax withholding16,073$68.15KForm 4
Jan 31, 2026Horga Maria ArantxaChief Medical OfficerOption exercise51,283—Form 4
Jun 20, 2025Adams Jerome M.DirectorOption exercise29,600—Form 4
Jun 20, 2025Polsky BruceDirectorOption exercise29,600—Form 4
Jun 20, 2025BERGER FRANKLIN MDirectorOption exercise29,600—Form 4
Jun 20, 2025Lucidi BrunoDirectorOption exercise29,600—Form 4
Jun 20, 2025Duncan Barbara GayleDirectorOption exercise29,600—Form 4
Jun 20, 2025Murphy Polly A.DirectorOption exercise29,600—Form 4
May 18, 2025Murphy Polly A.DirectorBuy6,100$25.45KForm 4
Jan 31, 2025Foster WayneEVP, Chief Accounting OfficerTax withholding12,062$36.91KForm 4
Jan 31, 2025Foster WayneEVP, Chief Accounting OfficerAward8,000—Form 4
Jan 31, 2025Foster WayneEVP, Chief Accounting OfficerOption exercise33,333—Form 4
Jan 31, 2025Vavricka JohnChief Commercial OfficerTax withholding11,517$35.24KForm 4
Jan 31, 2025Vavricka JohnChief Commercial OfficerAward8,750—Form 4
Jan 31, 2025Vavricka JohnChief Commercial OfficerOption exercise33,333—Form 4
Jan 31, 2025Sommadossi Jean-PierrePresident, CEO, and ChairmanTax withholding88,601$271.12KForm 4
Jan 31, 2025Sommadossi Jean-PierrePresident, CEO, and ChairmanAward99,517—Form 4
Jan 31, 2025Sommadossi Jean-PierrePresident, CEO, and ChairmanOption exercise173,467—Form 4
Jan 31, 2025Corcoran AndreaSee RemarksTax withholding16,102$49.27KForm 4
Jan 31, 2025Corcoran AndreaSee RemarksAward10,500—Form 4
Jan 31, 2025Corcoran AndreaSee RemarksOption exercise44,367—Form 4
Jan 31, 2025Horga Maria ArantxaChief Medical OfficerTax withholding16,071$49.18KForm 4
Jan 31, 2025Horga Maria ArantxaChief Medical OfficerAward9,750—Form 4
Jan 31, 2025Horga Maria ArantxaChief Medical OfficerOption exercise41,533—Form 4
Jan 31, 2025Hammond Janet MJChief Development OfficerTax withholding14,134$43.25KForm 4
Jan 31, 2025Hammond Janet MJChief Development OfficerAward11,250—Form 4
Jan 31, 2025Hammond Janet MJChief Development OfficerOption exercise46,800—Form 4
Jan 16, 2025BERGER FRANKLIN MDirectorBuy10,000$33.61KForm 4
Jan 16, 2025BERGER FRANKLIN MDirectorBuy10,000$33.61KForm 4
Jan 15, 2025BERGER FRANKLIN MDirectorBuy15,000$47.88KForm 4
Jan 15, 2025BERGER FRANKLIN MDirectorBuy15,000$47.88KForm 4
Dec 10, 2024BERGER FRANKLIN MDirectorSale359,606$1.02MForm 4
Sep 19, 2024Sommadossi Jean-PierrePresident, CEO, and ChairmanSale1,841$7.37KForm 4
Sep 18, 2024Sommadossi Jean-PierrePresident, CEO, and ChairmanSale22,187$89.47KForm 4
Sep 17, 2024Sommadossi Jean-PierrePresident, CEO, and ChairmanSale33,941$137.32KForm 4
Jun 20, 2024Polsky BruceDirectorSale17,544$61.14KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related